Tectonic Therapeutic | AVRO - Selling And Administration Expenses


Tectonic Therapeutic reported $3.44M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alnylam Pharmaceuticals USD 285.06M 22.47M Dec/2025
Celltrion KRW 249.98B 16.36B Sep/2025
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 6.57M 1.62M Dec/2025
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Gilead Sciences USD 1.78B 425M Dec/2025
Ionis Pharmaceuticals USD 130M 43.43M Dec/2025
Kangmei Pharma CNY 274.41M 15.05M Sep/2025
Karyopharm Therapeutics USD 9.56M 17.63M Dec/2025
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
MacroGenics USD 7.94M 1.96M Dec/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 2.84M 4.19M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
Organigram Holdings CAD 7.73M 1.13M Dec/2025
Ovoca Bio EUR 632K 2.33M Jun/2025
Pfizer USD 4.08B 894M Dec/2025
Pharma Mar EUR 17.31M 3.6M Dec/2025
Qiagen NV USD 153.88M 10.77M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sangamo BioSciences USD 9.64M 1.83M Jun/2024
Sanofi EUR 2.75B 455M Dec/2025
Sarepta Therapeutics USD 105.38M 28.27M Dec/2025
Sartorius EUR 218.7M 6.5M Sep/2025
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Takeda JPY 282.78B 29.23B Dec/2025
Tilray USD 24.85M 1.7M Sep/2025
Zealand Pharma A/S 91.81M 99.04M Dec/2025
Zz Pientze Pharmaceu CNY 171.91M 343.2M Sep/2025